Disclaimer: This page contains content specific to Florida Stem Cell Law, which allows specific licensed physicians to administer stem cell therapies that the U.S. Food and Drug Administration has not approved. The law and the content apply to providers licensed in Florida under Chapter 458 (Medical Doctors) and Chapter 459 (Osteopathic Physicians) acting in the course and scope of their employment.
Stem cell therapy utilizes the body’s most versatile cellular resources to support tissue repair, attenuate inflammation, and improve functional outcomes across a range of conditions. These cells exhibit self-renewal and the capacity to differentiate into multiple specialized lineages, and their paracrine signaling activity underpins many of the observed benefits in orthopedics, chronic pain, dermatology, wound healing, and other degenerative pathologies.
Mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, or umbilical cord blood are the most widely employed in clinical and investigational protocols because of their regenerative, anti-inflammatory, and immunomodulatory properties. Umbilical cord–derived MSCs, in particular, are biologically “younger,” ethically obtained from perinatal tissues, and demonstrate robust proliferative and immunoregulatory profiles, making them an attractive source for advanced regenerative applications.
Stem cells are a class of undifferentiated cells with the remarkable ability to self-renew (produce copies of themselves) and differentiate (transform into specialized cell types, such as muscle, nerve, or blood cells). This capacity can inspire confidence in patients and professionals by highlighting their potential for tissue repair and regeneration.
There are several types of stem cells based on their potency:
Stem cells can be derived from sources such as bone marrow, adipose tissue, umbilical cord blood, and induced pluripotent stem cells, with cord blood and Wharton’s Jelly MSCs gaining preference for their regenerative potential and ethical sourcing.
Stem cells are specialized cells in your body that can develop into various types of cells, depending on the body’s needs. Imagine stem cells as nature’s repair team; they go to the damaged area and become the cells your body needs to heal, whether it’s muscle, cartilage, skin, or even nerves.
What’s remarkable about stem cells is their ability to self-renew. They produce more stem cells, creating a continuous supply for your body to repair itself naturally. This ability to transform into specific cell types makes stem cells ideal for treating injuries, pain, wounds, and degenerative conditions such as arthritis and nerve damage. There are different types of stem cells in your body, and they all have a special role in helping your body heal.
For further information on stem cell properties, refer to PubMed’s comprehensive database: PubMed – Stem Cell Research.
Stem cells contribute to tissue regeneration mainly through differentiation into needed cell types and paracrine signaling, which influences surrounding cells and promotes healing.
For in-depth stem cell differentiation research and mechanisms, explore resources on PubMed: Stem Cell Differentiation and Mechanisms.
When you receive stem cell therapy, stem cells travel to the damaged area in your body and transform into the type of cell your body needs, like bone cells, muscle cells, or cartilage cells. This process helps repair and regenerate damaged tissue.
But stem cells do more than create new cells. They also send healing signals to the surrounding cells. These signals help reduce inflammation, prevent cell death, and stimulate the growth and healing of other cells. This ability to influence their environment makes stem cells a potent therapeutic tool for various conditions, including joint pain and sports injuries, to address pain, repair non-healing wounds, repair nerve damage, and support organ repair, according to multiple studies.
Wharton’s Jelly mesenchymal stem cells (WJ-MSCs) are multipotent stromal cells isolated from the gelatinous substance within the human umbilical cord known as Wharton’s jelly. These cells are notable for:
Overall, Wharton’s Jelly MSCs represent an excellent source of regenerative cells with applications in tissue engineering, immunotherapy, and regenerative medicine.
Cord blood-derived mesenchymal stem cells (MSCs) have become a preferred source for stem cell therapy due to their superior regenerative capacity, immunomodulatory properties, and ethical sourcing. MSCs derived from cord blood (the blood left in the umbilical cord after birth) have several significant advantages over adult-derived MSCs:
These advantages make cord blood MSCs superior for regenerative therapies targeting various degenerative conditions, wound healing, pain, and autoimmune issues.
Cord blood comes from the umbilical cord after birth, and it’s a rich source of stem cells that are stronger and more effective than adult stem cells. Because these stem cells are younger, they are better at regenerating tissue and repairing damage. Plus, cord blood collection is non-invasive, meaning no harm to the baby or the mother.
Cord blood-derived stem cells also have a lower risk of rejection because they have not been exposed to the environmental stressors that adult stem cells face. This makes them an excellent option for patients who need regenerative treatments and immune modulation.
For studies on cord blood-derived MSCs, see research articles on PubMed: Cord Blood Stem Cells.
The source and method of harvesting stem cells significantly impact their therapeutic potential, safety, and ethical acceptability. Cord blood-derived mesenchymal stem cells (MSCs) are obtained from the umbilical cord and placenta immediately after childbirth. The collection process is non-invasive and poses no risk to the mother or child. After collection, the cord blood is processed under sterile conditions, and stem cells are isolated using density gradient centrifugation or immuno-selection techniques. These cells are processed under Good Manufacturing Practice (GMP) conditions to ensure quality, viability, and safety.
Key advantages of this harvesting method include:
For deeper reading on harvesting techniques and safety standards, see: PubMed – Cord Blood MSC Processing Techniques.
Stem cells from umbilical cord blood are collected safely after a baby is born. It’s a simple, painless process that doesn’t harm the mother or baby. These stem cells are then cleaned, stored, and processed in labs for later use to help treat injuries, arthritis, or nerve damage.
In the context of stem cell culture, “doubling no more than 12 times” means that the population of stem cells has undergone no more than 12 rounds of doubling since their initial isolation and culture. Each population doubling represents one complete doubling of the cell number (e.g., from 1,000 to 2,000 cells is one doubling). The population doubling level (PDL) is tracked to measure a cell population’s cellular age or total replication history in vitro.
Tracking and limiting PDL is vital because:
In summary, a PDL limit of 12 ensures you’re working with stem cells that have not been excessively expanded, helping maintain desirable biological properties and compliance with best practices in research and clinical settings.
When dealing with stem cells, the number of passages means that the cell culture has been split and subcultured four times since the initial plating. Each passage involves detaching cells (usually with enzymes or mechanical means) and transferring them to new culture vessels with fresh growth media. This helps prevent overcrowding and keeps the cells proliferating in optimal conditions. The passage number indicates how many times this transfer process has occurred in that cell population.
For instance, stem cells at passage four have been through four subculturing rounds since they were initially isolated or thawed from a stock. The passage number is significant because stem cell characteristics—such as their growth rate, differentiation capacity, and phenotype—can change over successive passages and affect efficacy and potency.
In the context of stem cells, “secretome” refers to the complete set of molecules (such as proteins, cytokines, growth factors, exosomes, and other substances) secreted by stem cells into their environment. These molecules are responsible for many beneficial effects of stem cell therapies, including promoting tissue repair, reducing inflammation, and signaling other cells to function or regenerate.
When someone mentions “20 x the secretome,” it typically means that the stem cell product or treatment contains secretome components at a concentration 20 times the baseline, standard, or normal level. This could mean the secretome has been concentrated to be much more potent, or that it is derived from a larger initial number of stem cells, resulting in a higher quantity of bioactive factors responsible for therapeutic effects.
In summary, “20 x the secretome” indicates a highly concentrated stem cell secretome product that may be intended to have enhanced therapeutic impact compared to a standard secretome preparation.
Culturing stem cells on human media—meaning media that do not contain animal-derived components (like fetal bovine serum) but instead use human-derived or fully defined and Xeno-free ingredients—offers several significant advantages:
Overall, human media (or Xeno-free, chemically defined media) provides safety, consistency, and suitability for clinical translation—critical advantages for stem cell research and therapy.
Stem cell therapy has wide applications across various clinical fields due to its ability to regenerate tissues and modulate immune responses:
For more clinical insights and research on stem cell therapy applications, visit: Clinical Trials – Stem Cell Applications.
Stem cell therapy can help you recover from:
For a more comprehensive guide on patient outcomes with stem cell therapies, refer to PubMed: Stem Cell Therapy for Joint Pain and Inflammation.
A common concern is whether donor DNA or elements, such as the COVID-19 vaccine’s spike protein, can be transmitted to recipients through stem cell therapy. Scientific evidence shows that:
For safety, all donor tissues undergo rigorous screening, including testing for infectious diseases and recent vaccination status. Following COVID-19 vaccination, the spike protein degrades within days and is not detectable in stored or cultured mesenchymal stem cells (MSCs) used for therapy.
Further studies: PubMed – Stem Cells and Donor DNA Safety, PubMed – Vaccine Components and Stem Cells.
People sometimes worry that stem cells might carry donor DNA or even parts of the COVID-19 vaccine. But that’s not how stem cells work. They don’t stay in your body long-term or mix with your DNA. And if a donor has had a vaccine, the body breaks down the vaccine’s protein in just a few days—it’s not present in the stem cells you receive.
Another concern in regenerative medicine is whether stem cells or exosomes may stimulate tumor growth. The current scientific consensus is nuanced:
Ongoing research is necessary, especially in patients with a history of cancer. Clinicians are advised to screen patients thoroughly and evaluate risks on a case-by-case basis.
See:
Some people wonder whether stem cells or exosomes could contribute to cancer progression. Research indicates that when stem cells are obtained from healthy sources and thoroughly tested, they do not pose a risk of causing cancer. They’re used safely in many therapies. But doctors will always check your history to make sure the treatment is safe for you, especially if you’ve had cancer before.
Stem cells offer several distinct advantages over traditional therapies, including:
Stem cell therapy differs in that it focuses on repairing the underlying cause of your condition, rather than merely masking its symptoms. Whether treating joint pain, muscle damage, or wounds, stem cells offer a natural healing solution that can regenerate tissue and support long-term recovery without invasive surgery or medications.
Before offering stem cell therapy to a patient, a thorough assessment of the patient’s health status and suitability for stem cell treatment is essential. This includes:
If you’re considering stem cell therapy, be sure to discuss the following with your healthcare provider:
Success rates based on your specific condition and medical history.